Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding
Conditions
Abnormal Uterine Bleeding
Conditions: official terms
Hemorrhage - Uterine Hemorrhage
Conditions: Keywords
Transvaginal sonography, Endometrial thickness, Endometrial pattern, Abnormal uterine bleeding, Endometrial hyperplasia, Endometrial cancer
Study Type
Interventional
Study Phase
N/A
Study Design
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Intervention
Name: Transvaginal sonography
Type: Device
Overall Status
Not yet recruiting
Summary
The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with abnormal uterine bleeding.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 35 Years
Gender: Female
Criteria: Inclusion Criteria:

- Premenopausal women aged over than 35

- Abnormal uterine bleeding (menorrhagia/menometrorrhagia/metrorrhagia)

- Accept transvaginal examination (pelvic examination and ultrasound)

- Informed consent

Exclusion Criteria:

- Severe uterine bleeding resulting in unstable vital signs

- Pregnancy

- Current medications: anticoagulants, selective serotonin reuptake inhibitor (SSRI), antipsychotics, corticosteroids, hormones, herbs

- Intrauterine device

- Genital tract pathologies: infection, submucous myoma distorting uterine cavity

- Systemic diseases that may cause coagulopathies: Thyroid disease, liver disease, pituitary/ hypothalamus diseases

- Not able to retrieve endometrial tissue
Location
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand
Status: Not yet recruiting
Contact: Porntip Sirayapiwat, MD, MSc - 662-256-4241 - p_siraya@hotmail.com
Start Date
February 2013
Completion Date
March 2014
Sponsors
Chulalongkorn University
Source
Chulalongkorn University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page